human
noroviru
infect
major
diseas
burden
studi
analyz
three
new
norovirusspecif
nanobodi
interact
prototyp
human
noroviru
ie
genogroup
genotyp
show
nanobodi
bound
side
top
capsidprotrud
p
domain
use
xray
crystallographi
bound
similar
region
p
domain
orient
two
nanobodi
clash
shell
domain
neighbor
p
domain
intact
particl
find
suggest
p
domain
particl
shift
order
bind
intact
particl
interestingli
capabl
block
noroviru
viruslik
particl
vlp
bind
histoblood
group
antigen
hbga
import
cofactor
noroviru
infect
previous
show
hbga
pocket
could
block
solubl
human
milk
oligosaccharid
current
studi
show
combin
treatment
enhanc
block
potenti
addit
synergist
effect
also
found
gii
nanobodi
also
enhanc
inhibit
nanobodi
inhibit
like
occur
differ
mechan
includ
particl
aggreg
particl
disassembl
wherea
block
hbga
bind
site
overal
new
data
show
posit
effect
addit
limit
singl
mode
action
nanobodi
singl
noroviru
genogroup
import
discoveri
vulner
region
noroviru
particl
instrument
develop
effect
inhibitor
particularli
gi
norovirus
genet
divers
analysi
nanobodi
shown
similar
gii
noroviru
particl
gi
particl
vulner
region
known
cofactor
region
hbga
bind
pocket
repres
main
target
inhibit
combin
treatment
ie
addit
effect
inhibit
increas
therefor
combin
drug
treatment
might
offer
better
approach
combat
noroviru
infect
especi
sinc
gi
genotyp
highli
divers
continu
chang
capsid
landscap
conserv
epitop
far
identifi
base
capsid
gene
sequenc
norovirus
divid
least
seven
genogroup
gi
gvii
gi
gii
giv
caus
infect
human
human
genogroup
subdivid
numer
genotyp
noroviru
virion
compris
dimer
form
icosahedr
particl
nm
diamet
capsid
protein
express
insect
cell
selfassembl
viruslik
particl
vlp
assum
morpholog
similar
nativ
virion
xray
crystal
structur
prototyp
genogroup
genotyp
gi
noroviru
vlp
show
capsid
divid
two
domain
shell
protrud
p
domain
connect
via
flexibl
hing
domain
form
scaffold
surround
rna
surfaceexpos
p
domain
subdivid
subdomain
contain
main
determin
antigen
host
bind
epitop
noroviru
interact
cofactor
histoblood
group
antigen
hbga
import
infect
eg
although
certain
genotyp
poorli
bind
hbga
eg
hbga
found
solubl
antigen
saliva
express
epitheli
cell
studi
indic
noroviru
may
interact
hbga
prior
cell
attach
andor
bind
particl
cell
surfac
recent
studi
show
human
monoclon
antibodi
mab
target
hbga
pocket
inhibit
noroviru
vlp
bind
hbga
steric
interfer
hbga
pocket
previou
studi
identifi
norovirusspecif
singlechain
variabl
domain
nanobodi
block
gii
noroviru
vlp
bind
hbga
also
show
human
milk
oligosaccharid
hmo
eg
block
hbga
bind
pocket
hmo
third
abund
compound
human
milk
shown
protect
variou
pathogen
hmo
structur
resembl
hbga
complex
glycan
consist
differ
link
monosaccharid
hmo
thought
act
receptor
decoy
mimick
hbga
thu
block
viru
attach
mani
antivir
insuffici
crossreact
among
divers
noroviru
genotyp
appear
limit
factor
broadrang
therapi
virus
enhanc
effect
achiev
joint
administr
sever
compound
inde
current
stateoftheart
therapi
take
advantag
drug
combin
approach
addit
synergist
effect
administr
combin
drug
enhanc
effect
without
increas
overal
dose
drug
interact
magnifi
effect
independ
act
differ
target
site
ultim
compound
complement
maxim
respons
rate
gener
highli
effici
combin
therapi
current
standard
treatment
guidelin
hiv
infect
three
synergist
act
drug
use
compound
differ
drug
class
target
distinct
stage
viru
life
cycl
suppress
viru
prolifer
investig
synergist
addit
drug
effect
common
antivir
research
varieti
virus
hepat
b
viru
hbv
dengu
viru
addit
sever
studi
shown
synergist
effect
viral
inhibitor
target
stage
viral
attach
combin
differ
neutral
mab
exhibit
posit
effect
number
differ
virus
hiv
hepat
c
viru
sever
acut
respiratori
syndrom
sar
coronaviru
furthermor
synergist
inhibit
hiv
observ
combin
solubl
form
receptor
combin
differ
neutral
mab
combin
antivir
activ
drug
also
demonstr
studi
use
rotaviru
anoth
common
caus
gastroenter
studi
combin
plant
extract
plantderiv
compound
shown
synergist
increas
inhibit
rotaviru
replic
vitro
current
studi
determin
xray
crystal
structur
three
novel
nanobodi
complex
p
domain
show
bound
side
p
domain
wherea
bound
top
data
suggest
might
clash
domain
neighbor
p
domain
would
mean
p
reminisc
unbound
p
domain
electron
densiti
nanobodi
well
resolv
typic
immunoglobulin
fold
bind
site
similarli
locat
side
p
domain
wherea
bound
top
crystal
structur
p
complex
crystal
structur
p
complex
solv
resolut
bound
side
p
domain
grove
two
p
domain
monom
fig
interact
subdomain
residu
well
p
domain
monom
includ
main
side
chain
fig
seven
subdomain
four
subdomain
residu
interact
form
vast
network
direct
hydrogen
bond
addit
hydrogen
bond
electrostat
hydrophob
interact
subdomain
residu
also
observ
overal
held
copiou
p
domain
residu
residu
interact
observ
date
norovirusspecif
nanobodi
inde
find
like
relat
subnanomolar
affin
fig
interestingli
bound
way
end
opposit
complementaritydetermin
region
cdr
loop
nanobodi
might
contact
domain
neighbor
p
domain
superposit
p
complex
onto
vlp
structur
show
clash
domain
well
neighbor
p
domain
fig
result
exampl
titrat
upper
graph
shown
bind
isotherm
calcul
use
singl
bind
site
model
subtract
heat
dilut
lower
graph
three
nanobodi
exhibit
nanomolar
bind
affin
subnanomolar
stoichiometri
show
exotherm
bind
wherea
bound
endotherm
bind
reaction
character
exotherm
type
reaction
suggest
neighbor
p
domain
andor
domain
would
need
move
order
bind
intact
particl
observ
elisa
fig
crystal
structur
p
complex
structur
p
complex
solv
resolut
similar
found
bound
side
p
domain
grove
two
p
domain
monom
fig
howev
compar
fewer
direct
hydrogen
bond
observ
contribut
subdomain
residu
fig
likewis
electrostat
hydrophob
interact
provid
subdomain
residu
fig
overal
p
domain
interact
residu
subdomain
residu
contrast
half
total
interact
residu
locat
interestingli
also
orient
way
one
site
nanobodi
clash
domain
neighbor
p
domain
fig
surprisingli
find
similar
fig
moreov
sever
gii
nanobodi
shown
bind
occlud
region
capsid
howev
case
gii
vlp
p
domain
rais
domain
might
allow
nanobodi
squeez
region
p
domain
crystal
structur
p
complex
structur
p
complex
solv
resolut
bound
top
p
domain
interact
one
p
domain
monom
fig
direct
hydrogen
bond
well
electrostat
hydrophob
interact
observ
fig
bind
residu
except
one
locat
subdomain
interestingli
bind
pocket
close
proxim
hbga
pocket
lack
common
bind
residu
align
capsid
residu
interact
nanobodi
order
better
understand
nanobodi
genotyp
specif
align
capsid
sequenc
gi
genotyp
fig
overal
gi
capsid
sequenc
rather
variabl
compar
gii
sequenc
nanobodi
bind
residu
locat
region
p
domain
includ
mixtur
conserv
variabl
residu
find
correspond
well
lack
nanobodi
crossreact
among
gi
genotyp
addit
discoveri
suggest
lack
capsid
conserv
like
limit
abil
identifi
crossreact
gi
nanobodi
observ
mab
studi
hbgablock
assay
previou
studi
show
gii
nanobodi
could
block
attach
porcin
gastric
mucin
pgm
consequ
evalu
whether
fig
xray
crystal
structur
p
domain
complex
asymmetr
unit
contain
one
p
domain
dimer
gray
two
molecul
green
bound
side
p
domain
b
closeup
p
dimer
interact
residu
p
domain
hydrogen
bond
interact
includ
sidechain
mainchain
interact
monom
direct
hydrogen
bond
form
p
domain
chain
chain
b
electrostat
interact
form
p
domain
chain
chain
b
hydrophob
interact
involv
p
domain
chain
chain
b
nanobodi
also
block
vlp
attach
pgm
use
similar
block
assay
fig
found
weakli
block
vlp
attach
pgm
wherea
block
vlp
dosedepend
manner
halfmaxim
inhibitori
concentr
ic
gml
gml
respect
result
similar
gii
nanobodi
nanobodi
capabl
block
despit
bind
similar
region
p
domain
tempt
specul
greater
number
subdomain
residu
interact
compar
influenc
abil
inhibit
bind
hbga
although
direct
evid
lack
anoth
mechan
might
relat
alloster
inhibit
sinc
similar
find
observ
sever
giispecif
nanobodi
vlp
structur
integr
upon
nanobodi
treatment
order
evalu
gi
nanobodi
might
alter
stabil
intact
vlp
measur
diamet
nanobodytr
vlp
use
dynam
light
scatter
dl
untreat
vlp
exhibit
singl
peak
indic
homogen
sampl
vlp
diamet
nm
fig
incub
vlp
dramat
increas
heterogen
led
peak
shift
nm
suggest
treatment
caus
particl
aggreg
contrast
treatment
affect
vlp
diamet
fig
directli
observ
effect
nanobodytr
vlp
examin
use
em
fig
treatment
either
vlp
morpholog
remain
compar
untreat
vlp
wherea
treatment
observ
larg
aggreg
vlp
result
confirm
dl
data
moreov
electron
microscopi
em
result
suggest
particl
aggreg
like
block
vlp
bind
pgm
earlier
studi
show
inhibit
vlp
bind
pgm
ic
mm
therefor
examin
possibl
combin
nanobodi
might
enhanc
hbgablock
potenti
pgmblock
assay
vlp
preincub
serial
dilut
combin
constant
concentr
mm
fig
combin
led
enhanc
inhibit
indic
advers
effect
occur
nanobodi
moreov
extent
inhibit
enhanc
correl
increas
concentr
suggest
synergist
effect
fig
c
therefor
mathemat
model
bliss
independ
use
deter
mine
nanobodi
act
addit
synergist
manner
combin
mm
mm
defin
synergist
sinc
alon
alreadi
show
high
inhibit
calcul
valu
expect
addit
effect
exceed
full
inhibit
fig
e
accord
criterion
synergist
effect
data
indic
synerg
variou
concentr
exampl
mm
combin
gml
mm
combin
gml
strongest
synergist
effect
observ
combin
mm
differ
expect
addit
observ
synergist
valu
statist
signific
p
determin
pair
test
twoway
analysi
varianc
anova
observ
inhibit
combin
rang
gml
combin
mm
close
match
expect
valu
addit
two
singl
effect
fig
j
result
indic
combin
treatment
effect
addit
combin
gii
nanobodi
treatment
analyz
whether
posit
effect
nanobodi
combin
genogroup
depend
repeat
combin
inhibit
assay
gii
vlp
treat
giispecif
fig
assay
concentr
reduc
mm
sinc
ic
vlp
mm
serial
dilut
mix
mm
combin
mm
increas
inhibit
effect
compar
alon
suggest
concentr
low
combin
mm
inhibit
attach
vlp
pgm
greater
extent
alon
indic
posit
cooper
effect
nanobodi
bind
noroviru
journal
virolog
combin
observ
effect
match
calcul
expect
addit
accord
bliss
independ
criterion
effect
determin
addit
overal
result
show
posit
effect
combin
nanobodi
genogroup
specif
studi
analyz
three
new
nanobodi
bound
side
top
p
domain
show
bound
way
opposit
end
cdr
clash
domain
neighbor
p
domain
model
vlp
structur
fig
interestingli
phenomenon
also
observ
gii
nanobodi
gii
diagnost
igg
mab
specul
like
gii
vlp
p
domain
abil
shift
order
bind
nanobodi
understand
p
domain
shift
particl
could
critic
import
sinc
current
vaccin
clinic
trial
use
noroviru
vlp
two
human
noroviru
vlp
structur
determin
resolut
clearli
distinguish
p
domain
ie
xray
structur
cryoem
structur
major
differ
gi
gii
vlp
structur
p
domain
rest
rais
domain
respect
one
possibl
reason
might
relat
techniqu
use
prepar
vlp
crystal
p
domain
could
compact
domain
wherea
cryoem
vitreou
ice
layer
might
allow
p
domain
less
compress
clearli
highresolut
cryoem
structur
vlp
would
requir
confirm
sampl
prepar
influenc
vlp
structur
anoth
explan
might
simpli
signifi
uniqu
structur
differ
two
genogroup
still
new
nanobodi
bind
interact
occlud
bind
site
suggest
p
domain
vlp
probabl
flexibl
previous
realiz
notion
gi
gii
particl
conceal
vulner
epitop
occlud
region
rais
sever
new
line
question
exampl
p
domain
movement
advantag
disadvantag
viru
function
p
domain
movement
shown
gii
vlp
treat
citrat
increas
particl
diamet
might
make
viru
noninfecti
also
shown
gii
nanobodi
could
transform
natives
vlp
smaller
vlp
nm
diamet
current
develop
longterm
immun
current
vlp
vaccin
unclear
might
relat
particl
flexibl
vlp
prepar
requir
investig
perhap
lock
p
domain
defin
posit
could
confer
better
host
immun
vaccin
respons
previou
studi
identifi
sever
nanobodi
bound
occlud
epitop
still
abl
effici
inhibit
vlp
attach
pgm
similarli
gi
nanobodi
also
bound
occlud
region
fig
also
show
effici
inhibit
vlp
attach
pgm
mechan
appar
involv
neither
direct
steric
interfer
particl
aggreg
disrupt
one
possibl
mode
inhibit
could
bind
lower
region
p
domain
induc
conform
chang
capsid
subsequ
interf
abil
vlp
bind
hbga
comparison
bind
show
bind
site
similar
yet
inhibitori
properti
rather
differ
influenc
particl
structur
inhibit
hbga
bind
contrast
shown
induc
particl
disassembl
upon
bind
vlp
therefor
effect
inhibit
hbga
bind
result
suggest
specif
interact
well
nanobodi
orient
respect
p
domain
import
term
nanobodi
could
influenc
viral
integr
also
stress
fact
attach
similar
bind
site
strongli
inhibit
hbga
bind
wherea
inhibit
like
inhibit
hbga
attach
induc
particl
aggreg
panel
gii
nanobodi
found
caus
particl
aggreg
well
case
induc
rearrang
p
domain
loop
subsequ
led
alter
surfac
hydrophob
minor
rearrang
p
domain
loop
observ
impli
mode
aggreg
differ
case
bind
character
posit
enthalpi
chang
coupl
larg
posit
entropi
chang
main
contribut
factor
free
energi
chang
sinc
minor
structur
rearrang
p
domain
occur
upon
nanobodi
bind
structur
respect
complex
could
fit
well
xray
structur
vlp
howev
fit
nanobodyp
domain
complex
possibl
posit
vlp
structur
reveal
steric
clash
capsid
likewis
similar
steric
clash
observ
overal
result
suggest
hing
region
p
domain
might
intrins
flexibl
allow
bind
intact
particl
anoth
import
find
current
studi
combin
treatment
nanobodi
improv
attach
inhibit
case
treatment
result
synergist
inhibitori
effect
inhibit
might
occur
differ
mechan
exampl
treatment
led
fast
sever
aggreg
vlp
remain
nonaggreg
vlp
inhibit
altern
aggreg
vlp
reduc
number
bind
site
concentr
rel
remain
avail
bind
site
higher
data
suggest
inhibit
hbga
attach
compromis
stabil
vlp
inhibit
bind
hbga
compar
combin
treatment
vlp
orang
led
consider
diamet
increas
particl
aggreg
compar
vlp
alon
black
green
cyan
treatment
affect
particl
size
experi
perform
natives
norwalk
viru
vlp
b
em
analysi
untreat
nanobodytr
vlp
treatment
produc
larg
aggreg
intact
natives
vlp
wherea
obviou
chang
caus
addit
increas
inhibit
case
addit
increas
inhibit
also
observ
howev
reason
inhibit
clear
except
bound
mani
p
domain
residu
known
nanobodi
might
indirectli
affect
hbga
bind
overal
new
data
show
posit
effect
addit
limit
singl
mode
action
nanobodi
singl
noroviru
genogroup
prophylact
set
nanobodi
combin
therapi
might
result
increas
inhibit
noroviru
infect
nanobodi
alreadi
use
prophylact
treatment
virus
treatment
nanobodi
show
promis
result
number
viral
infect
includ
hiv
influenza
viru
human
respiratori
syncyti
viru
rsv
rotaviru
one
studi
show
oral
administr
rotavirusspecificnanobodi
effect
treat
rotavirusinduc
diarrhea
anim
model
also
show
nanobodi
interfer
host
humor
antibodi
respons
wherea
igg
antibodi
treatment
develop
respons
other
conclud
passiv
nanobodi
treatment
safe
high
efficaci
one
bestknown
exampl
use
nanobodi
viru
infect
rsv
research
show
intranas
administr
bival
rsvspecif
nanobodi
protect
mice
infect
type
treatment
could
provid
immedi
protect
host
certainli
exploit
human
norovirus
inhibit
studi
plan
human
noroviru
cell
cultur
system
product
noroviru
p
domain
vlp
p
domain
norwalk
viru
genbank
access
produc
previous
describ
briefli
p
domain
clone
modifi
express
vector
transform
escherichia
coli
cell
grown
lb
medium
h
express
induc
mm
isopropyl
iptg
od
h
cell
harvest
centrifug
disrupt
sonic
ice
histag
fusionp
domain
protein
purifi
ni
column
qiagen
digest
proteas
novagen
overnight
cleav
p
domain
separ
ni
column
dialyz
gel
filtrat
buffer
gfb
mm
trishcl
ph
mm
nacl
overnight
p
domain
purifi
sizeexclus
chromatographi
concentr
mgml
gfb
store
product
noroviru
vlp
genbank
access
strain
west
chester
genbank
access
strain
genbank
access
strain
southampton
genbank
access
strain
genbank
access
strain
genbank
access
strain
express
insect
cell
capsid
sequenc
vlp
west
chester
use
immun
alpaca
close
relat
amino
acid
differ
sequenc
determin
norwalk
viru
vlp
structur
pdb
id
product
nanobodi
produc
previous
describ
vib
nanobodi
servic
facil
approv
ethic
commiss
vrije
universiteit
brussel
belgium
briefli
singl
alpaca
inject
subcutan
vlp
vhh
librari
construct
screen
presenc
antigenspecif
nanobodi
nanobodi
subclon
express
vector
express
e
coli
cell
overnight
express
induc
mm
iptg
od
nanobodi
extract
periplasm
supernat
collect
nanobodi
elut
ni
column
seri
wash
step
purifi
sizeexclus
chromatographi
nanobodi
concentr
mgml
store
gfb
direct
elisa
microtit
plate
maxisorp
thermo
scientif
coat
lwell
gml
p
domain
vlp
h
plate
wash
three
time
phosphatebuff
salin
ph
contain
tween
pbst
subsequ
block
skim
milk
pb
h
room
temperatur
serial
dilut
pb
start
gml
appli
wash
elisa
plate
incub
h
nanobodi
detect
horseradish
peroxidaseconjug
monoclon
antibodi
polyhistidin
sigma
dilut
pb
plate
wash
develop
ophenylenediamin
h
opd
buffer
dark
min
room
temperatur
final
reaction
stop
volvol
hcl
absorpt
nm
od
measur
cutoff
limit
set
od
time
valu
pb
neg
control
isotherm
titrat
calorimetri
measur
isotherm
titrat
calorimetri
itc
experi
perform
use
malvern
uk
sampl
dialyz
pb
filter
prior
titrat
experi
titrat
perform
inject
consecut
l
l
aliquot
nanobodi
p
domain
interv
bind
data
correct
heat
dilut
fit
onesit
bind
model
calcul
equilibrium
bind
constant
k
bind
paramet
n
chang
enthalpi
bind
site
assum
ident
crystal
noroviru
p
domain
nanobodi
complex
p
domain
mix
separ
molar
ratio
complex
incub
h
complex
purifi
sizeexclus
chromatographi
use
column
concentr
mgml
complex
crystal
grown
use
hangingdrop
vapor
diffus
method
mother
solut
contain
sodium
citrat
ph
wtvol
polyethylen
glycol
day
crystal
grown
mother
solut
contain
ammonium
acet
sodium
citrat
ph
volvol
glycerol
wtvol
prior
flashfreez
liquid
nitrogen
singl
crystal
transfer
cryoprotect
contain
mother
liquor
without
ethylen
glycol
data
collect
structur
solut
refin
xray
diffract
data
collect
european
synchrotron
radiat
facil
franc
beamlin
process
xd
p
domain
complex
solv
use
molecular
replac
p
domain
pdb
id
previous
determin
nanobodi
pdb
id
search
model
phaser
complex
structur
refin
multipl
round
manual
model
build
coot
refin
phenix
structur
valid
coot
molprob
pdbepisa
server
use
determin
bind
interfac
calcul
surfac
area
bind
interact
analyz
use
accelri
discoveri
studio
hydrogen
bond
interact
distanc
hydrophob
interact
distanc
figur
protein
contact
potenti
gener
use
pymol
http
pymolorg
dynam
light
scatter
hydrodynam
size
vlp
analyz
use
dynam
light
scatter
dl
zetas
nano
system
malvern
vlp
nanobodi
l
incub
min
room
temperatur
dilut
ml
distil
water
measur
measur
perform
three
run
measur
cycl
electron
microcopi
noroviru
vlp
morpholog
treat
untreat
analyz
use
negativestain
electron
microscopi
em
previous
describ
nanobodi
mgml
vlp
mgml
mix
equal
volum
incub
h
room
temperatur
prior
load
carbonco
em
grid
sampl
quickli
dilut
time
distil
water
grid
wash
distil
water
stain
uranyl
acet
grid
examin
zeiss
electron
microscop
hbgablock
assay
bind
vlp
porcin
gastric
mucin
pgm
type
iii
contain
hbga
previous
determin
block
assay
microtit
plate
maxisorp
thermo
scientif
coat
lwell
pgm
gml
sigma
h
plate
wash
three
time
phosphatebuff
salin
ph
contain
tween
pbst
subsequ
block
skim
milk
pb
h
room
temperatur
serial
dilut
pb
ad
vlp
final
concentr
gml
min
room
temperatur
plate
wash
three
time
pbst
l
vlpnanobodi
mixtur
ad
triplic
well
h
wash
l
biotinyl
nanobodi
ad
follow
wash
step
horseradish
peroxidas
hrp
conjug
streptavidin
monoclon
antibodi
ad
well
incub
h
plate
wash
develop
ophenylenediamin
dihydrochlorid
opd
h
dark
min
room
temperatur
final
reaction
stop
n
hcl
absorb
nm
od
measur
gi
neg
control
gi
posit
control
use
control
experi
od
valu
untreat
vlp
set
refer
valu
correspond
bind
percentag
inhibit
calcul
treat
vlp
mean
od
mean
refer
od
halfmaxim
inhibitori
concentr
ic
determin
use
prism
softwar
version
experi
pgm
bind
perform
triplic
standard
deviat
calcul
dual
treatment
similar
approach
perform
except
serial
dilut
combin
constant
concentr
final
concentr
mm
similar
assay
block
attach
pgm
combin
examin
assay
incub
time
temperatur
differ
slightli
due
differ
vlp
use
coat
perform
h
room
temperatur
block
done
overnight
treat
vlp
incub
h
room
temperatur
vlp
detect
use
polyclon
rabbit
antibodi
h
room
temperatur
polyclon
antirabbithrp
conjug
h
room
temperatur
bliss
independ
calcul
evalu
interact
bliss
independ
employ
data
analysi
hbgablock
assay
model
assum
stochast
process
compound
contribut
final
result
act
independ
target
differ
site
expect
addit
effect
calcul
base
probabl
independ
block
activ
nanobodi
nanobodi
e
follow
equat
e
nanobodi
e
e
e
nanobodi
e
e
nanobodi
e
comparison
calcul
expect
addit
effect
observ
result
demonstr
drug
interact
zero
interact
appli
effect
two
drug
addit
consequ
measur
valu
drug
combin
close
calcul
theoret
addit
valu
observ
combin
valu
expect
addit
valu
synergist
effect
impli
observ
valu
expect
addit
antagon
impli
determin
differ
expect
addit
observ
inhibit
statist
signific
perform
pair
twotail
test
singl
data
point
twoway
anova
data
avail
atom
coordin
structur
factor
complex
deposit
protein
data
bank
access
number
p
complex
p
complex
p
complex
